TotalMarketCap

Olema Pharmaceuticals

OLMANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$593.671 M

$6.79 -10.01%

Close of 6 Nov 2026

As of 6 Nov 2026, Olema Pharmaceuticals (OLMA) has a market capitalization of $593.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$162.5M

Loss-making

Shares outstanding

87,497,607

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #177ArriVent BioPharmaAVBP$602.5M
  2. #178Immix BiopharmaIMMX$597.3M
  3. #179Olema PharmaceuticalsOLMA$593.7M
  4. #180ApnimedAPMD$589.1M
  5. #181Arbutus BiopharmaABUS$561.8M

What if Olema Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$322,715.96

Per share 47,563× higher

Bitcoin $1.53T

$17,461.60

Per share 2,574× higher

Apple $5.02T

$57,324.80

Per share 8,449× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Olema Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.